Mosaic Biosciences Raises $1.0M
Boulder-based Mosaic Biosciences, a developer of synthetic materials to help promote new tissue regeneration, has raised $1.0M in a funding round, according to a regulatory filing from the firm this week. The firm's website indicates the round was a Series A, and included Morgenthaler Ventures, HealthCare Ventures, and High Country Venture. The firm's CEo is Marty Stanton, who has previously served at Somalogic, BiOptix, Archemix, Sierra, and Dexela. The firm's founders include researchers from CU Boulder, Dr. Kristi Anseth and Dr. Chris Bowman, both of Cu's Departmnet of Chemical and Biological Engineering. Mosaic said its technology can be applied to wound healing, bone regeneration, cartilage repair, stem cell therapy, and dermal fillers.
posted on Friday, July 22, 2011 (Link to more information)
Related companies:
Mosaic Biosciences, Inc.
Related stories:
> JDA Software Expands Relationship with U.K. Client
> HireVue Helps Marketer
> Numira Biosciences Buys Firm
> Frontier Scientific Acquires Echelon Biosciences
> Vivint Smart Home Goes Public Via Reverse Merger
Techrockies.com Home